🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

14 results for “Tarsus Pharmaceuticals” Clear

  1. TP-03

    Tarsus Pharmaceuticals

    Blepharitis

    phase 3 small molecule completed

    1 trial

  2. TP-03, 0.25%

    Tarsus Pharmaceuticals

    Blepharitis

    phase 3 small molecule completed

    1 trial

  3. Lotilaner Gel, 2.0%

    Tarsus Pharmaceuticals

    Papulopustular Rosacea

    phase 2 small molecule completed

    1 trial

  4. Low Dose TP-05

    Tarsus Pharmaceuticals

    Healthy Volunteer

    phase 2 small molecule completed

    1 trial

  5. TP-03

    Tarsus Pharmaceuticals

    Meibomian Gland Dysfunction

    phase 2 small molecule completed

    1 trial

  6. TP-05 (lotilaner) Low Dose

    Tarsus Pharmaceuticals

    Lyme Disease

    phase 2 small molecule active

    1 trial

  7. Vehicle of TP-03

    Tarsus Pharmaceuticals

    Meibomian Gland Dysfunction

    phase 2 small molecule active

    1 trial

  8. lotilaner

    Tarsus Pharmaceuticals

    Ocular Rosacea

    phase 2 small molecule active

    1 trial

  9. TP-03 (Lotilaner Ophthalmic Solution), 0.25%

    Tarsus Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  10. TP-05 (lotilaner oral capsules)

    Tarsus Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  11. TP-05 (lotilaner oral), fasted group

    Tarsus Pharmaceuticals

    Healthy

    phase 1 small molecule completed

    1 trial

  12. Lotilaner ophthalmic solution, 0.25%

    Tarsus Pharmaceuticals

    Demodex Blepharitis

    approved small molecule completed

    1 trial

  13. Standart medical treatment

    Tarsus Pharmaceuticals

    High Intensity Interval Training

    small molecule active

    1 trial

  14. Uteratonic administration

    Tarsus Pharmaceuticals

    Placenta Abruptio

    small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources